CD8A and neoplasm: Whereas our study is the first to evaluate ICI-induced changes in peripheral blood of mUC patients, upregulation of cell cycle genes and increases in Ki-67+ CD8+ T cells during anti-PD-1 therapy have previously been described in other tumor types.